Abstract
BackgroundCancer immunotherapies can produce complete therapeutic responses, however, outcomes in ovarian cancer (OC) are modest. While adoptive T-cell transfer (ACT) has been evaluated in OC, durable effects are rare. Poor...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have